Volume 18, Number 4—April 2012
Dispatch
Human Parvovirus 4 Infection, Cameroon
Myriam Lavoie, Colin P. Sharp, Jacques Pépin
, Christopher Pennington, Yacouba Foupouapouognigni, Oliver G. Pybus, Richard Njouom, and Peter Simmonds
, Christopher Pennington, Yacouba Foupouapouognigni, Oliver G. Pybus, Richard Njouom, and Peter Simmonds
Table 1
Prevalence of human parvovirus 4 by patient characteristics, Cameroon, 2009*
| Characteristic | No. virus positive/ no. tested (%) | p value |
|---|---|---|
| Age, y | 0.04 | |
| 60–64 | 32/125 (26) | |
| 65–69 | 13/96 (14) | |
| 70–74 | 17/103 (17) | |
| >75 | 17/127 (13) | |
| Sex | 0.15 | |
| M | 25/178 (14) | |
| F | 54/273 (20) | |
| HCV serologic results | 0.61 | |
| Negative | 29/178 (16) | |
| Positive | 47/252 (19) | |
| Anti-HBcAg | 1.00 | |
| Negative | 3/21 (14) | |
| Positive | 76/430 (18) | |
| Treponemal antibodies | 0.06 | |
| Absent | 28/119 (24) | |
| Present | 51/332 (15) | |
| Intravenous treatment for malaria | 0.04 | |
| No | 29/216 (13) | |
| Yes | 50/235 (21) | |
| Intravenous treatment for other diseases | 0.93 | |
| No | 42/239 (18) | |
| Yes | 37/212 (17) | |
| No. past intravenous treatments | 0.38 | |
| 0 | 12/88 (14) | |
| 1–3 | 33/206 (16) | |
| >4 | 25/116 (22) | |
| Unknown | 9/41 (22) | |
| Tuberculosis | 0.04 | |
| No | 72/433 (17) | |
| Yes, treated with oral drugs only | 4/12 (33) | |
| Yes, treatment included streptomycin | 3/6 (50) | |
| Transfusion | 0.09 | |
| No | 76/408 (19) | |
| Yes | 3/43 (7) | |
| Depo-Provera injections† | 0.006 | |
| No | 50/268 (19) | |
| Yes | 4/5 (80) | |
| Scarifications | 0.88 | |
| No | 30/165 (18) | |
| Yes | 49/286 (17) | |
| Vaccine scar, left arm | 0.005 | |
| Absent | 17/53 (32) | |
| Present | 61/397 (15) | |
| Vaccine scar, right arm | 0.76 | |
| Absent | 27/165 (16) | |
| Present | 51/284 (18) | |
| Circumcision (males only) | 0.74 | |
| Medical | 9/73 (12) | |
| Traditional | 16/105 (15) | |
*HCV, hepatitis C virus, HBcAg, hepatitis B core antigen.
†Pharmacia & Upjohn Company, New York, NY, USA.
Page created: March 15, 2012
Page updated: March 15, 2012
Page reviewed: March 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.